Recent progress and clinical importance on pharmacogenetics in cancer therapy

by Soh, T.I.P., Yong, W.P., Innocenti, F.
Published 2014

Targeted therapy at the end of life in advanced cancer patients

by Soh, T.I.P., Yuen, Y.-C., Teo, C., Lim, S.-W., Chan, N., Wong, A.S.C.
Published 2014

Common bile duct obstruction by intraluminal colorectal metastasis without evidence of liver or intraabdominal nodal metastasis

by Soh, T.I.P., Doshi, B.K., Putti, T.C., Ang, B.W.L., Aw, D.C.W., Cheong, W.K., Lee, S.-C., Chuah, B.Y.S.
Published 2014

Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?

by Chan D.Y.S., Syn N.L.-X., Yap R., Phua J.N.S., Soh T.I.P., Chee C.E., Nga M.E., Shabbir A., So J.B.Y., Yong W.P.
Published 2018

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

by Wong A.L.A., Sundar R., Wang T.-T., Ng T.-C., Zhang B., Tan S.-H., Soh T.I.P., Pang A.S.L., Tan C.-S., Ow S.G.W., Wang L., Mogro J., Ho J., Jeyasekharan A.D., Huang Y., Thng C.-H., Chan C.-W., Hartman M., Iau P., Buhari S.A., Goh B.-C., Lee S.-C.
Published 2020